Category: Clinical Trials

CAR-T Today and Tomorrow: Clinical Decision-Making and Patient Support

Tara Gregory, MD, Colorado Blood Cancer Institute, Denver, CO and Jay Spiegel, MD, Sylvester Comprehensive Cancer Center, Miami, FL

Driving Progress in AML

David Sallman, MD, Moffitt Cancer Center, Tampa, FL

Key Insights from Attending ASH 2025

Lore Gruenbaum, PhD, Blood Cancer United, Washington, DC

Understanding MRD: Insights for clinical practice and patient care

Rahul Banerjee, MD, FACP, Fred Hutchinson Cancer Center, Seattle, WA

Pediatric Acute Leukemias: Focus on clinical trials for treatment

Ann Collins, PA, Blood Cancer United, Washington, DC, Kelly Laschinger, MSN, RN, CPNP, CPHON, Blood Cancer United, Washington, DC, Sarah K. Tasian, MD, Children’s Hospital of Philadelphia, Philadelphia, PA

Highlights from attending the 2023 ASH Annual Meeting

Lee Greenberger, PhD, The Leukemia & Lymphoma Society, Rye Brook, NY

Scroll to Top